HuMax

HuMax is an abbreviation for "human monoclonal antibody targeting...", used by the pharmaceutical company Genmab in trade names. Examples include:

HuMax-CD4 (zanolimumab)
HuMax-CD20 (ofatumumab)
HuMax-EGFr (zalutumumab)

This article includes a list of related items that share the same name (or similar names).
If an internal link incorrectly led you here, you may wish to change the link to point directly to the intended article.